| n | MSI positive | Univariate analysis | Multivariate analysis | |||
---|---|---|---|---|---|---|---|
n | % | Odd’s ratio (95% confidence interval) | P value | Odd’s ratio (95% confidence interval) | P value | ||
Patient | |||||||
 Age | |||||||
   ≤ 50y.o. | 86 | 19 | 22.1% | 2.11 (1.17–3.82) | 0.02 |  |  |
   > 50y.o | 380 | 45 | 11.8% |  |  |  |  |
 Gender | |||||||
  Male | 283 | 36 | 12.7% | 0.81 (0.48–1.37) | 0.49 |  |  |
  Female | 183 | 28 | 15.3% |  |  |  |  |
Personal and/or family history | |||||||
 AII criteria | |||||||
  (+) | 40 | 17 | 42.5% | 5.96 (3.00–11.87) | < 0.0001 |  |  |
  (−) | 426 | 47 | 11.0% |  |  |  |  |
 rB guidelines | |||||||
  (+) | 259 | 51 | 19.7% | 3.66 (1.93–6.94) | < 0.0001 |  |  |
  (−) | 207 | 13 | 6.3% |  |  |  |  |
  ≥ 3 LS(rB)-related cancers# in FDR, SDR and TDR | |||||||
  (+) | 51 | 17 | 33.3% | 3.91 (2.03–7.55) | 0.0001 |  |  |
  (−) | 415 | 47 | 11.3% |  |  |  |  |
  ≥ 3 any cancers in FDR, SDR and TDR | |||||||
  (+) | 120 | 27 | 22.5% | 2.43 (1.41–4.18) | 0.002 |  |  |
  (−) | 346 | 37 | 10.7% |  |  |  |  |
 Colorectal cancer patient in FDR | |||||||
  (+) | 132 | 30 | 22.7% | 2.60 (1.52–4.44) | 0.001 | 9.98 (1.47–205.1) | 0.046 |
  (−) | 334 | 34 | 10.2% |  |  |  |  |
Colorectal cancer | |||||||
 Location | |||||||
  Right-side colon | 155 | 42 | 27.1% | 4.88 (2.80–8.51) | < 0.0001 | 5.21(2.61–10.81) | < 0.0001 |
  Left-side colon | 311 | 22 | 7.1% |  |  |  |  |
 Stage | |||||||
  Early | 39 | 12 | 30.8% | 3.21 (1.55–6.65) | 0.003 |  |  |
  Advanced | 427 | 52 | 12.2% |  |  |  |  |
 Multiplicity (simultaneous + metachronous) | |||||||
  (+) | 49 | 15 | 30.6% | 3.31 (1.70–6.47) | 0.001 |  |  |
  (−) | 417 | 49 | 11.8% |  |  |  |  |
 Purpose of MSI test | |||||||
  Genetic counseling | 127 | 53 | 41.7% | 21.36 (10.74–42.40) | < 0.0001 | 24.98 (10.07–70.08) | < 0.0001 |
  Companion diagnostics | 339 | 11 | 3.2% |  |  |  |  |